(Q73510789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

G Fanghänel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Cortinas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Sánchez-Reyes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Berber

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

144-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994).

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Weight as a risk factor for clinical diabetes in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

A prospective study of body mass index, weight change, and risk of stroke in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

A commentary on weighing the options: criteria for evaluating weight-management programs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Maintenance of Weight Loss: A Needs Assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Thermogenic effects of sibutramine in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Sibutramine in weight control: a dose-ranging, efficacy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

A double-blind randomized placebo-controlled trial of sibutramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Pharmacotherapy for obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801098

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0801098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10702763%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference